VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CNMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CNMDCONMED Corporation
$45.80$1.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCNMDQuarterly Financials

CONMED Corporation (CNMD) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

CONMED Corporation (CNMD) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

CNMD Income Statement

Quarterly statement

CNMD Income Statement

CONMED Corporation (CNMD) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue343.49M317.05M373.47M338.58M343.04M319.4M345.94M316.7M332.1M312.27M327.05M304.58M317.65M295.47M250.87M275.09M277.19M242.33M273.97M248.83M
Revenue Growth %0.13%-0.74%7.96%6.91%3.29%2.28%5.78%3.98%4.55%5.69%30.37%10.72%14.6%21.93%-8.43%10.55%8.63%4.15%8.36%4.62%
Cost of Goods Sold146.03M133.6M160.15M180.62M162.52M151.52M147.6M137.71M148.37M140.31M144.87M136.52M146.96M140.15M119M123.47M125.41M106.34M118.11M106.52M
COGS % of Revenue42.51%42.14%42.88%53.35%47.38%47.44%42.67%43.48%44.68%44.93%44.3%44.82%46.27%47.43%47.44%44.88%45.24%43.88%43.11%42.81%
Gross Profit197.46M183.45M213.33M157.96M180.52M167.89M198.34M179M183.73M171.97M182.18M168.06M170.69M155.32M131.86M151.62M151.78M135.99M155.86M142.31M
Gross Margin %57.49%57.86%57.12%46.65%52.62%52.56%57.33%56.52%55.32%55.07%55.7%55.18%53.73%52.57%52.56%55.12%54.76%56.12%56.89%57.19%
Gross Profit Growth %9.38%9.27%7.55%-11.75%-1.75%-2.37%8.88%6.51%7.64%10.72%38.16%10.85%12.46%14.21%-15.39%6.54%7.32%5.87%15.01%6.44%
Operating Expenses161.05M158.03M146.45M138.56M138.8M156.41M145.84M113.29M136.62M136.95M131.99M137.76M143.27M142.62M132.96M127.37M127.32M113.55M118.64M115.59M
OpEx % of Revenue46.89%49.85%39.21%40.92%40.46%48.97%42.16%35.77%41.14%43.86%40.36%45.23%45.1%48.27%53%46.3%45.93%46.86%43.3%46.46%
Selling, General & Admin145.55M141.7M131.56M124.66M124.66M143.46M132.67M99.73M122.52M123.36M117.96M125.3M129.7M130.08M120.74M114.6M115.83M102.88M107.28M104.74M
SG&A % of Revenue42.38%44.69%35.22%36.82%36.34%44.92%38.35%31.49%36.89%39.5%36.07%41.14%40.83%44.03%48.13%41.66%41.79%42.45%39.16%42.09%
Research & Development15.5M16.33M14.9M13.9M14.14M12.95M13.18M13.56M14.1M13.59M14.03M12.46M13.57M12.54M12.22M12.77M11.49M10.67M11.36M10.86M
R&D % of Revenue4.51%5.15%3.99%4.11%4.12%4.05%3.81%4.28%4.25%4.35%4.29%4.09%4.27%4.24%4.87%4.64%4.15%4.4%4.15%4.36%
Other Operating Expenses00000000000000000000
Operating Income36.41M25.41M66.87M19.4M41.72M11.48M52.5M65.71M47.11M35.01M50.19M30.3M27.42M12.7M-1.09M24.25M24.46M22.44M37.22M26.71M
Operating Margin %10.6%8.02%17.91%5.73%12.16%3.59%15.18%20.75%14.18%11.21%15.35%9.95%8.63%4.3%-0.44%8.81%8.82%9.26%13.58%10.73%
Operating Income Growth %-12.74%121.4%27.38%-70.48%-11.44%-67.22%4.61%116.85%71.81%175.71%4683.29%24.96%12.1%-43.42%-102.94%-9.22%-4.86%11.76%50.67%-9.09%
EBITDA58.45M38.29M85.72M32.48M54.88M24.41M70.5M83.68M64.95M53.05M68.19M42.93M40.38M30.63M16.64M41.88M36.72M39.27M54.69M43.92M
EBITDA Margin %17.02%12.08%22.95%9.59%16%7.64%20.38%26.42%19.56%16.99%20.85%14.09%12.71%10.37%6.63%15.22%13.25%16.21%19.96%17.65%
EBITDA Growth %6.5%56.83%21.58%-61.19%-15.49%-53.98%3.4%94.94%60.83%73.18%309.74%2.51%9.99%-22%-69.57%-4.66%-3.1%2.39%27.98%-7.24%
D&A (Non-Cash Add-back)22.05M12.87M18.85M13.08M13.17M12.94M18.01M17.97M17.84M18.04M18M12.63M12.96M17.93M17.74M17.63M12.26M16.83M17.48M17.21M
EBIT39.23M25.41M36.62M11.88M37.74M15.96M52.5M65.71M47.11M35.01M50.19M30.3M27.42M12.7M-1.09M24.25M-87.55M22.44M37.22M25.58M
Net Interest Income0-7.06M-7.37M-7.61M-7.82M-8.29M-8.86M-9.25M-9.59M-9.59M-9.5M-10.02M-10M-10.26M-9.44M-8.54M-5.93M-5M-7.57M-8.14M
Interest Income00000000000000000000
Interest Expense7.88M7.06M7.37M7.61M7.82M8.29M8.86M9.25M9.59M9.59M9.51M10.02M10M10.26M9.44M8.54M5.93M5M7.57M8.14M
Other Income/Expense-5.06M-7.06M-37.62M-15.13M-11.8M-3.81M-8.86M-9.25M-9.59M-9.59M-9.5M-10.02M-10M-10.26M-9.44M-8.54M-117.94M-5M-7.57M-9.27M
Pretax Income31.35M18.36M29.25M4.27M29.92M7.67M43.64M56.45M37.51M25.42M40.68M20.28M17.42M2.44M-10.54M15.71M-93.48M17.45M29.65M17.44M
Pretax Margin %9.13%5.79%7.83%1.26%8.72%2.4%12.62%17.83%11.3%8.14%12.44%6.66%5.48%0.83%-4.2%5.71%-33.72%7.2%10.82%7.01%
Income Tax8.28M4.53M12.51M1.41M8.5M1.64M9.89M7.47M7.54M5.71M7.61M4.44M3.69M625K-37.12M-30.44M74.81M2.47M5.2M2.49M
Effective Tax Rate %26.4%24.66%42.78%33.09%28.4%21.32%22.65%13.23%20.09%22.46%18.71%21.91%21.18%25.57%352.27%-193.72%-80.03%14.16%17.55%14.28%
Net Income23.07M13.83M16.74M2.86M21.42M6.04M33.76M48.98M29.98M19.71M33.07M15.84M13.73M1.82M26.58M46.15M-168.29M14.97M24.44M14.95M
Net Margin %6.72%4.36%4.48%0.84%6.24%1.89%9.76%15.47%9.03%6.31%10.11%5.2%4.32%0.62%10.6%16.78%-60.71%6.18%8.92%6.01%
Net Income Growth %7.7%129.09%-50.41%-94.16%-28.54%-69.37%2.07%209.3%118.29%983.51%24.4%-65.68%108.16%-87.85%8.75%208.74%-1366.3%51.88%1.26%118.22%
Net Income (Continuing)23.07M13.83M16.74M2.86M21.42M6.04M33.76M48.98M29.98M19.71M33.07M15.84M13.73M1.82M26.58M46.15M-168.29M14.97M24.44M14.95M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.770.450.540.090.690.191.081.570.960.631.050.500.430.060.861.48-5.650.430.750.47
EPS Growth %11.59%136.84%-50%-94.13%-28.13%-69.84%2.86%214%123.26%980.62%22.09%-66.22%107.61%-86.44%14.67%214.89%-1478.05%38.71%-7.41%104.35%
EPS (Basic)0.770.450.540.090.690.191.091.590.970.641.080.520.450.060.871.51-5.650.430.830.51
Diluted Shares Outstanding30.12M30.62M31.03M31.05M31.05M31.15M31.11M31.11M31.11M31.27M31.5M31.69M31.8M31.2M30.93M31.1M29.77M35.16M32.77M32.14M
Basic Shares Outstanding30.07M30.59M30.97M30.95M30.95M30.97M30.85M30.86M30.81M30.78M30.76M30.74M30.66M30.51M30.48M30.47M29.77M35.16M29.35M29.18M
Dividend Payout Ratio--36.99%216.47%28.88%102.39%18.3%12.58%20.54%31.22%18.59%38.8%44.49%335.24%22.93%13.2%-39.23%23.88%39%